Seamus Mulligan - Net Worth and Insider Trading
Seamus Mulligan Net Worth
The estimated net worth of Seamus Mulligan is at least $147 Million dollars as of 2024-11-13. Seamus Mulligan is the Director of Jazz Pharmaceuticals PLC and owns about 1,152,788 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $147 Million. Details can be seen in Seamus Mulligan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Seamus Mulligan has not made any transactions after 2020-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Seamus Mulligan
Seamus Mulligan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Seamus Mulligan owns 2 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) , and Emergent BioSolutions Inc (EBS) .
Click here to see the complete history of Seamus Mulligan’s form 4 insider trades.
Insider Ownership Summary of Seamus Mulligan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2020-05-27 | director |
| EBS | Emergent BioSolutions Inc | 2019-03-19 | director |
Seamus Mulligan Latest Holdings Summary
Seamus Mulligan currently owns a total of 1 stock. Seamus Mulligan owns 1,152,788 shares of Jazz Pharmaceuticals PLC (JAZZ) as of May 27, 2020, with a value of $147 Million.
Latest Holdings of Seamus Mulligan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2020-05-27 | 1,152,788 | 127.60 | 147,095,749 |
Holding Weightings of Seamus Mulligan
Seamus Mulligan Form 4 Trading Tracker
According to the SEC Form 4 filings, Seamus Mulligan has made a total of 1 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the acquisition of 50,000 shares on May 27, 2020, which cost Seamus Mulligan around $6 Million.
Insider Trading History of Seamus Mulligan
- 1
Seamus Mulligan Trading Performance
GuruFocus tracks the stock performance after each of Seamus Mulligan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seamus Mulligan is 1.19%. GuruFocus also compares Seamus Mulligan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seamus Mulligan within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Seamus Mulligan's insider trading performs compared to the benchmark.
Performance of Seamus Mulligan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.48 | | | | | |
| Relative Return to S&P 500(%) | -0.65 | | | | | |
Seamus Mulligan Ownership Network
Ownership Network List of Seamus Mulligan
Ownership Network Relation of Seamus Mulligan
Seamus Mulligan Owned Company Details
What does Jazz Pharmaceuticals PLC do?
Who are the key executives at Jazz Pharmaceuticals PLC?
Seamus Mulligan is the director of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include director & Executive Chairman Bruce C Cozadd , SVP & Technical Operations Mary Elizabeth Henderson , and VP & Finance& PAO Patricia Carr .
Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary
Over the past 18 months, Seamus Mulligan made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Mark Douglas Smith .
In summary, during the past 3 months, insiders sold 2,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 2,410 shares. During the past 18 months, 34,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 22,900 shares.
Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jazz Pharmaceuticals PLC Insider Transactions
Seamus Mulligan Mailing Address
Above is the net worth, insider trading, and ownership report for Seamus Mulligan. You might contact Seamus Mulligan via mailing address: 45 Fitzwilliam Square, Dublin L2 2.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
